Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to trigger sufficient levels of insulin production in a phase 1/2 trial.

Vertex holds a dominant position in the cystic franchise (“CF”) market. Its CF sales continue to grow, driven by higher sales of Trikafta/Kaftrio in younger age groups. Vertex’s CF product ...

In the latest development, Google today announced that it would be adding Chirp 3 — its speech-to-text and HD text-to-speech models — to its Vertex AI development platform starting next week.

UPDATE — 3/24/25, 3:48 p.m. ET: Bob the Drag Queen confirmed Neil Patrick Harris felt badly about forgetting Bob was on The Traitors. “He was very embarrassed because his husband, David ...

Neil Patrick Harris has undergone a drastic transformation for his role in the new Dexter series Resurrection. The star will appear in the latest franchise spinoff in the role of Lowell ...

Donald Trump caught former Vice President Kamala Harris and her aides off guard when the typically abrasive president politely praised her as a “tough cookie” and congratulated her on running ...

Memphis basketball coach Penny Hardaway is not ready to rule out either of his injured guards — Tyrese Hunter or Dante Harris — for March Madness. The No. 16th-ranked Tigers (29-5) earned a 5 ...

Husbands Neil Patrick Harris, 51, and David Burtka, 49, marked their 21st anniversary with social media postings. On Instagram [above], Harris posted a cute photo of him and Burtka and said ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best ...

Former Vice President Kamala Harris was floored by her loss to President Trump this past November, having “bought the hype” that her campaign was in good shape in the run-up to Election Day ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...